Opioids and Traffic Safety - Focus on Buprenorphine

Pharmacopsychiatry

Volumn 47, Issue 1, 2014, Pages 7-17

  Soyka, M ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Privatklinik Meiringen ^*  (Switzerland)

Author keywords

buprenorphine; cognition; driving ability; opioid dependence; opioids

Indexed keywords

ACCIDENTS, TRAFFIC; ANALGESICS, OPIOID; AUTOMOBILE DRIVING; BUPRENORPHINE; HUMANS; SUBSTANCE-RELATED DISORDERS;

EID: 84895064048     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0033-1358707     Document Type: Review

References (146)

1. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Annual report on the state of the drugs problem in Europe. Lisbon EMCDDA: 2011
2. United Nations Office on Drugs and Crime 2006 World Drug Report. Vienna UNODC: 2006
3. Hser Y. I., Hoffman V., Grella C. E. et al. 33-year follow-up of narcotics addicts. Arch Gen Psychiatry: 2001; 58 503 508
4. Termorshuizen F., Krol A., Prins M. et al. Long-term outcome of chronic drug use: the Amsterdam Cohort Study among Drug Users. Am J Epidemiol: 2005; 161 271 279
5. Connock M., Juarez-Garcia A., Jowett S. et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess: 2007; 11 1 171 iii-iv
6. Kleber H. D., Weiss R. D., Anton R. F. Jr et al. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry: 2007; 164 5 123
7. Lingford-Hughes A. R., Welch S., Peters L. et al. BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. J Psychopharmacol: 2012; 26 899 952
8. Soyka M., Kranzler H. R., van den Brink W. et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence. World J Biol Psychiatry: 2011; 12 160 187
9. Gruber S. A., Silveri M. M., Yurgelun-Todd D. A. Neuropsychological consequences of opiate use. Neuropsychol Rev: 2007; 17 299 315
10. Mattick R. P., Ali R., White J. M. et al. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction: 2003; 98 441 452
11. Mattick R. P., Breen C., Kimber J. et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev: 2009; CD002209
12. Mattick R. P., Kimber J., Breen C. et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev: 2008; CD002207
13. Mammen K., Bell J. The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence. Expert Opin Pharmacother: 2009; 10 2537 2544
14. Soyka M., Trader A., Klotsche J. et al. Criminal behavior in opioid-dependent patients before and during maintenance therapy: 6-year follow-up of a nationally representative cohort sample. J Forensic Sci: 2012; 57 1524 1530
15. Kelly E., Darke S., Ross J. A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions. drug Alcohol Rev: 2004; 23 319 344
16. Penning R., Veldstra J. L., Daamen A. P. et al. Drugs of Abuse, driving and traffic safety. Curr Drug Abuse Rev: 2010; 3 23 32
17. Strand M. C., Fjeld B., Arnestad M. et al. Can patients receiving opioid maintenance therapy safely drive? A systematic review of epidemiological and experimental studies on driving ability with a focus on concomitant methadone or buprenorphine administration. Traffic Inj Prev: 2013; 14 26 38
18. Corsenac P., Lagarde E., Gadegbeku B. et al. Road traffic crashes and prescribed methadone and buprenorphine: a French registry-based case-control study. Drug Alcohol Depend: 2012; 123 91 97
19. Callaghan R. C., Gatley J. M., Veldhuizen S. et al. Alcohol- or drug-use disorders and motor vehicle accident mortality: a retrospective cohort study. Accid Anal Prev: 2013; 53 149 155
20. Monarrez-Espino J., Moller J., Berg H. Y. et al. Analgesics and road traffic crashes in senior drivers: An epidemiological review and explorative meta-analysis on opioids. Accid Anal Prev: 2013; 57 157 164
21. Gomes T., Redelmeier D. A., Juurlink D. N. et al. Opioid dose and risk of road trauma in Canada: a population-based study. JAMA Intern Med: 2013; 173 196 201
22. Legrand S. A., Silverans P., de Paepe P. et al. Presence of psychoactive substances in injured Belgian drivers. Traffic Inj Prev: 2013; 14 461 468
23. Dassanayake T., Michie P., Carter G. et al. Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence. Drug Saf: 2011; 34 125 156
24. Hels T., Lyckegaard A., Simonsen K. W. et al. Risk of severe driver injury by driving with psychoactive susbtances. Accid Anal Prev: 2013; 59 346 356
25. Bukten A., Herskedal A., Skurtveit S. et al. Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study. Addiction: 2013; 10.1111/add.12275
26. Pluck G., Lee K. H., Rele R. et al. Premorbid and current neuropsychological function in opiate abusers receiving treatment. Drug Alcohol Depend: 2012; 124 181 184
27. Darke S., McDonald S., Kaye S. et al. Comparative patterns of cognitive performance amongst opioid maintenance patients, abstinent opioid users and non-opioid users. Drug Alcohol Depend: 2012; 126 309 315
28. Soyka M., Trader A., Klotsche J. et al. Six-year mortality rates of patients in methadone and buprenorphine maintenance therapy: results from a nationally representative cohort study. J Clin Psychopharmacol: 2011; 31 678 680
29. Kamien J. B., Branstetter S. A., Amass L. Buprenorphine-naloxone versus methadone maintenance therapy: a randomised double-blind trial with opioid-dependent patients. Heroin Addict Relat Clin Probl: 2008; 10 5 18
30. Ling W., Wesson D. R., Charuvastra C. et al. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry: 1996; 53 401 407
31. Schottenfeld R. S., Pakes J. R., Oliveto A. et al. Buprenorphine vs. methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry: 1997; 54 713 720
32. Davids E., Gastpar M. Buprenorphine in the treatment of opioid dependence. Eur Neuropsychopharmacol: 2004; 14 209 216
33. Kraus M. L., Alford D. P., Kotz M. M. et al. Statement of the American Society of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction. J Addict Med: 2011; 5 254 263
34. Auriacombe M., Franques P., Tignol J. Deaths attributable to methadone vs. buprenorphine in France. JAMA: 2001; 285 45
35. Pirnay S., Borron S. W., Giudicelli C. P. et al. A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction: 2004; 99 978 988
36. Mintzer M. Z., Copersino M. L., Stitzer M. L. Opioid abuse and cognitive performance. Drug Alcohol Depend: 2005; 78 225 230
37. Prosser J., Cohen L. J., Steinfeld M. et al. Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug Alcohol Depend: 2006; 84 240 247
38. Roncero C., Alavrez F. J., Barral C. et al. Driving and legal status of Spanish opioid-dependent patients. Substance Abuse Treatment Prev Policy: 2013; 8 19
39. Bachoo S., Bhagwanjee A., Govender K. The influence of anger, impulsivity, sensation seeking and driver attitudes on risky driving behaviour among post-graduate university students in Durban, South Africa. Accid Anal Prev: 2013; 55 67 76
40. Brandau H., Daghofer F., Hofmann M. et al. Personality subtypes of young moped drivers, their relationship to risk-taking behavior and involvement in road crashes in an Austrian sample. Accid Anal Prev: 2011; 43 1713 1719
41. Constantinou E., Panayiotou G., Konstantinou N. et al. Risky and aggressive driving in young adults: Personality matters. Accid Anal Prev: 2011; 43 1323 1331
42. Jakubczyk A., Klimkiewicz A., Wnorowska A. et al. Impulsivity, risky behaviors and accidents in alcohol-dependent patients. Accid Anal Prev: 2013; 51 150 155
43. Lev D., Hershkovitz E., Yechiam E. Decision making and personality in traffic offenders: a study of Israeli drivers. Accid Anal Prev: 2008; 40 223 230
44. Richer I., Bergeron J. Driving under the influence of cannabis: links with dangerous driving, psychological predictors, and accident involvement. Accid Anal Prev: 2009; 41 299 307
45. Ryb G. E., Dischinger P. C., Kufera J. A. et al. Risk perception and impulsivity: association with risky behaviors and substance abuse disorders. Accid Anal Prev: 2006; 38 567 573
46. Walsh J. M., Verstraete A. G., Huestis M. A. et al. Guidelines for research on drugged driving. Addiction: 2008; 103 1258 1268
47. Fishbain D. A., Cutler R. B., Rosomoff H. L. et al. Are opioid-dependent/tolerant patients impaired in driving-related skills? A structured evidence-based review. J Pain Symptom Manage: 2003; 25 559 577
48. Mintzer M. Z. Effects of opioid pharmacotherapy on psychomotor and cognitive performance: A review of human laboratory studies of methadone and buprenorphine. Heroin Addiction and Related Clinical Problems: 2007; 9 5 24
49. Morland J. Maintenance treatment and car driving. Maintenance treatment of heroin addiction: evidence at the crossroads. Oslo Cappelen Akademisk Forlag: 2003; 254 264
50. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Driving Under the influence of Drugs, Alcohol and Medicines in Europe - findings from the DRUID project. Lisbon EMCDDA: 2012
51. Mailis-Gagnon A., Lakha S. F., Furlan A. et al. Systematic review of the quality and generalizability of studies on the effects of opioids on driving and cognitive/psychomotor performance. Clin J Pain: 2012; 28 542 555
52. Orriols L., Salmi L. R., Philip P. et al. The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies. Pharmacoepidemiol Drug Saf: 2009; 18 647 658
53. Rapoport M. J., Lanctot K. L., Streiner D. L. et al. Benzodiazepine use and driving: a meta-analysis. J Clin Psychiatry: 2009; 70 663 673
54. Elvik R. Risk of road accident associated with the use of drugs: A systematic review and meta-analysis of evidence from epidemiological studies. Accid Anal Prev.: 2012; Jul 9. pii: S0001-4575(12)00241-2.doi: 10.1016/j.aap.2012.06.017
55. Asbridge M., Hayden J. A., Cartwright J. L. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ: 2012; 344 e536
56. Li M. C., Brady J. E., DiMaggio C. J. et al. Marijuana use and motor vehicle crashes. Epidemiol Rev: 2012; 34 65 72
57. Engeland A., Skurtveit S., Morland J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol: 2007; 17 597 602
58. Gibson J. E., Hubbard R. B., Smith C. J. et al. Use of self-controlled analytical techniques to assess the association between use of prescription medications and the risk of motor vehicle crashes. Am J Epidemiol: 2009; 169 761 768
59. Leveille S. G., Buchner D. M., Koepsell T. D. et al. Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology: 1994; 5 591 598
60. Movig K. L., Mathijssen M. P., Nagel P. H. et al. Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev: 2004; 36 631 636
61. Bachs L. C., Engeland A., Morland J. G. et al. The risk of motor vehicle accidents involving drivers with prescriptions for codeine or tramadol. Clin Pharmacol Ther: 2009; 85 596 599
62. Blomberg R. D., Preusser D. F. Narcotic use and driving behavior. Accid Anal Prev: 1974; 6 23 32
63. Maddux J. F., Williams T. R., Ziegler J. A. Driving records before and during methadone maintenance. Am J Drug Alcohol Abuse: 1977; 4 91 100
64. Babst D. V., Newman S., Gordon N. B. et al. Driving records of methadone maintenance patients in New York State. J Drug Issues: 1973; 3 285 292
65. Bramness J. G., Skurtveit S., Morland J. et al. An increased risk of motor vehicle accidents after prescription of methadone. Addiction: 2012; 107 967 972
66. Wiese Simonsen K., Steenttoft A., Bernhoft I. M. et al. Psychoactive substances in seriously injured drivers in Denmark. Forensic Sci Int: 2013; 224 44 50
67. Loeber S., Nakovics H., Kniest A. et al. Factors affecting cognitive function of opiate-dependent patients. Drug Alcohol Depend: 2012; 120 81 87
68. Baldacchino A., Balfour DJ K., Passetti F. et al. Neuropsychological consequences of chronic opioid use: A quantitative review and meta-analysis. Neurosci Biobehav Rev: 2012; 36 2056 2068
69. van Holst R. J., Schilt T. Drug-related decrease in neuropsychological functions of abstinent drug users. Curr Drug Abuse Rev: 2011; 4 42 56
70. Fernandez-Serrano M. J., Perez-Garcia M., Verdejo-Garcia A. What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neurosci Biobehav Rev: 2011; 35 377 406
71. Mintzer M. Z., Stitzer M. L. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend: 2002; 67 41 51
72. Batty G. D., Mortensen E. L., Osler M. Childhood IQ in relation to later psychiatric disorder: evidence from a Danish birth cohort study. Br J Psychiatry: 2005; 187 180 181
73. Verdejo-Garcia A., Del Mar Sanchez-Fernandez M., Alonso-Maroto L. M. et al. Impulsivity and executive functions in polysubstance-using rave attenders. Psychopharmacology (Berl): 2010; 210 377 392
74. Verdejo-Garcia A., Perez-Garcia M., Bechara A. Emotion, decision-making and substance dependence: a somatic-marker model of addiction. Curr Neuropharmacol: 2006; 4 17 31
75. Ersche K. D., Clark L., London M. et al. Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology: 2006; 31 1036 1047
76. Ersche K. D., Sahakian B. J. The neuropsychology of amphetamine and opiate dependence: implications for treatment. Neuoropsychology Rev: 2007; 17 317 336
77. Applebaum A. J., Otto M. W., Richardson M. A. et al. Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients. J Clin Exp Neuropsychol: 2010; 32 579 589
78. Passetti F., Clark L., Mehta M. A. et al. Neuropsychological predictors of clinical outcome in opiate addiction. Drug Alcohol Depend: 2008; 94 82 91
79. Dolcos F., Strungaru C., Dolcos S. M. et al. The involvement of endogenous opiates in emotional-cognitive interaction in stress. Rom J Physiol: 1998; 35 259 274
80. Barry D., Petry N. M. Predictors of decision-making on the Iowa Gambling Task: independent effects of lifetime history of substance use disorders and performance on the Trail Making Test. Brain Cogn: 2008; 66 243 252
81. Petrovic P., Pleger B., Seymour B. et al. Blocking central opiate function modulates hedonic impact and anterior cingulate response to rewards and losses. J Neurosci: 2008; 28 10509 10516
82. Davis P. E., Liddiard H., McMillan T. M. Neuropsychological deficits and opiate abuse. Drug Alcohol Depend: 2002; 67 105 108
83. Lee T. M., Pau C. W. Impulse control differences between abstinent heroin users and matched controls. Brain Inj: 2002; 16 885 889
84. Pau C. W., Lee T. M., Chan S. F. The impact of heroin on frontal executive functions. Arch Clin Neuropsychol: 2002; 17 663 670
85. Verdejo-Garcia A., Perez-Garcia M. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology (Berl): 2007; 190 517 530
86. Verdejo A., Toribio I., Orozco C. et al. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug Alcohol Depend: 2005; 78 283 288
87. Fernandez-Serrano M. J., Perez-Garcia M., Schmidt Rio-Valle J. et al. Neuropsychological consequences of alcohol and drug abuse on different components of executive functions. J Psychopharmacol: 2010; 24 1317 1332
88. Soyka M., Limmer C., Lehnert R. et al. A comparison of cognitive function in patients under maintenance treatment with heroin, methadone, or buprenorphine and healthy controls: an open pilot study. Am J Drug Alcohol Abuse: 2011; 37 497 508
89. Curran H. V., Kleckham J., Bearn J. et al. Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose-response study. Psychopharmacology (Berl): 2001; 154 153 160
90. Darke S., Sims J., McDonald S. et al. Cognitive impairment among methadone maintenance patients. Addiction: 2000; 95 687 695
91. Lyvers M., Yakimoff M. Neuropsychological correlates of opioid dependence and withdrawal. Addict Behav: 2003; 28 605 611
92. Goldstein R. Z., Volkow N. D. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci: 2011; 12 652 669
93. George O., Koob G. F. Individual differences in prefrontal cortex function and the transition from drug use to drug dependence. Neurosci Biobehav Rev: 2010; 35 232 247
94. th ed. Boca Raton CRC Press: 2009
95. Kurita G. P., Sjogren P., Ekholm O. et al. Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study. J Clin Oncol: 2011; 29 1297 1303
96. Kurita G. P., de Mattos Pimenta C. A., Braga P. E. et al. Cognitive function in patients with chronic pain treated with opioids: characteristics and associated factors. Acta Anaesthesiol Scand: 2012; 56 1257 1266
97. Landro N. I., Fors E. A., Vapenstad L. L. et al. The extent of neurocognitive dysfunction in a multidisciplinary pain centre population. Is there a relation between reported and tested neuropsychological functioning? Pain: 2013; 154 972 977
98. Michna E., Ross E. L., Hynes W. L. et al. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage: 2004; 28 250 258
99. Amato J. N., Marie S., Lelong-Boulouard V. et al. Effects of three therapeutic doses of codeine/paracetamol on driving performance, a psychomotor vigilance test, and subjective feelings. Psychopharmacology (Berl): 2013; Epub ahead of print
100. Soyka M. Safety aspects in methadone substitution - Part 1. Legal framework conditions, mortality, current results of treatment research. Suchtmed: 2008; 10 7 27
101. Soyka M. Safety aspects in methadone substitution - Part 2. Clinical-pharmacological aspects. Suchtmed: 2008; 10 119 144
102. Menefee L. A., Frank E. D., Crerand C. et al. The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions. Pain Med: 2004; 5 42 49
103. Ramaekers J. G. Pitfalls in estimating drug-related crash risk. Trends Pharmacol Sci: 2003; 24 114 115
104. Verster J. C., Veldhuijzen D. S., Volkerts E. R. Effects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood. Clin J Pain: 2006; 22 499 504
105. Andersen J. M., Olaussen C. F., Ripel A. et al. Long-term methadone treatment impairs novelty preference in rats both when present and absent in brain tissue. Pharmacol Biochem Behav: 2011; 98 412 416
106. Specka M., Finkbeiner T., Lodemann E. et al. Cognitive-motor performance of methadone-maintained patients. Eur Addict Res: 2000; 6 8 19
107. Gruber S. A., Tzilos G. K., Silveri M. M. et al. Methadone maintenance improves cognitive performance after two months of treatment. Exp Clin Psychopharmacol: 2006; 14 157 164
108. Soyka M., Zingg C., Koller G. et al. Cognitive function in short- and long-term substitution treatment: are there differences? World J Biol Psychiatry: 2010; 11 400 408
109. Bracken B. K., Trksak G. H., Penetar D. M. et al. Response inhibition and psychomotor speed during methadone maintenance: impact of treatment duration, dose, and sleep deprivation. Drug Alcohol Depend: 2012; 125 132 139
110. Messinis L., Lyros E., Andrian V. et al. Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy. Hum Psychopharmacol: 2009; 24 524 531
111. Baewert A., Gombas W., Schindler S. D. et al. Influence of peak and trough levels of opioid maintenance therapy on driving aptitude. Eur Addict Res: 2007; 13 127 135
112. Kagerer S., Backmund M., Walcher S. et al. Substitution with buprenorphine and driving ability - results of an experimental study. Suchtmed: 2002; 4 17 24
113. Lenne M. G., Dietze P., Rumbold G. R. et al. The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving. Drug Alcohol Depend: 2003; 72 271 278
114. Loeber S., Kniest A., Diehl A. et al. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment. Am J Drug Alcohol Abuse: 2008; 34 584 593
115. Pirastu R., Fais R., Messina M. et al. Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies. Drug Alcohol Depend: 2006; 83 163 168
116. Rapeli P., Fabritius C., Alho H. et al. Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls. BMC Clin Pharmacol: 2007; 7 5
117. Soyka M., Hock B., Kagerer S. et al. Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: results of a randomized clinical trial. J Clin Psychopharmacol: 2005; 25 490 493
118. Soyka M., Lieb M., Kagerer S. et al. Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial. J Clin Psychopharmacol: 2008; 28 699 703
119. Preston K. L., Bigelow G. E., Liebson I. A. Buprenorphine and naloxone alone and in combination in opioid-dependent humans. Psychopharmacology (Berl): 1988; 94 484 490
120. Singhal A., Tripathi B. M., Pal H. R. et al. Effect of buprenorphine on psychomotor functions in patients on buprenorphine maintenance. J Opioid Manag: 2008; 4 41 47
121. Strain E. C., Preston K. L., Liebson I. A. et al. Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers. J Pharmacol Exp Ther: 1992; 261 985 993
122. Strain E. C., Preston K. L., Liebson I. A. et al. Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone. J Pharmacol Exp Ther: 1995; 272 628 638
123. Strain E. C., Walsh S. L., Preston K. L. et al. The effects of buprenorphine in buprenorphine-maintained volunteers. Psychopharmacology (Berl): 1997; 129 329 338
124. Walsh S. L., June H. L., Schuh K. J. et al. Effects of buprenorphine and methadone in methadone-maintained subjects. Psychopharmacology (Berl): 1995; 119 268 276
125. Mintzer M. Z., Lanier R. K., Lofwall M. R. et al. Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers. Drug Alcohol Depend: 2010; 111 265 288
126. Jensen M. L., Sjogren P., Upton R. N. et al. Pharmacokinetic- pharmacodynamic relationships of cognitive and psychomotor effects of intravenous buprenorphine infusion in human volunteers. Basic Clin Pharmacol Toxicol: 2008; 103 94 101
127. MacDonald F. C., Gough K. J., Nicoll R. A. et al. Psychomotor effects of ketorolac in comparison with buprenorphine and diclofenac. Br J Clin Pharmacol: 1989; 27 453 459
128. Manner T., Kanto J., Salonen M. Simple devices in differentiating the effects of buprenorphine and fentanyl in healthy volunteers. Eur J Clin Pharmacol: 1987; 31 673 676
129. Saarialho-Kere U., Mattila M. J., Paloheimo M. et al. Psychomotor, respiratory and neuroendocrinological effects of buprenorphine and amitriptyline in healthy volunteers. Eur J Clin Pharmacol: 1987; 33 139 146
130. Zacny J. P., Conley K., Galinkin J. Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers. J Pharmacol Exp Ther: 1997; 282 1187 1197
131. Wang J. H., Liu X. F., Chen Y. M. et al. Heroin impairs map-picture-following and memory tasks dependent on gender and orientation of the tasks. Behav Neurosci: 2007; 121 653 664
132. Brand M., Roth-Bauer M., Driessen M. et al. Executive functions and risky decision-making in patients with opiate dependence. Drug Alcohol Depend: 2008; 97 64 72
133. Bruhn P., Maage N. Intellectual and neuropsychological functions in young men with heavy and long-term patterns of drug abuse. Am J Psychiatry: 1975; 132 397 401
134. Guerra D., Sole A., Cami J. et al. Neuropsychological performance in opiate addicts after rapid detoxification. Drug Alcohol Depend: 1987; 20 261 270
135. Ornstein T. J., Iddon J. L., Baldacchino A. M. et al. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology: 2000; 23 113 126
136. Pakesch G., Loimer N., Grunberger J. et al. Neuropsychological findings and psychiatric symptoms in HIV-1 infected and noninfected drug users. Psychiatry Res: 1992; 41 163 177
137. Rapeli P., Kivisaari R., Autti T. et al. Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry: 2006; 6 9
138. Fishbein D. H., Krupitsky E., Flannery B. A. et al. Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. Drug Alcohol Depend: 2007; 90 25 38
139. Mintzer M. Z., Correia C. J., Strain E. C. A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers. Drug Alcohol Depend: 2004; 74 205 209
140. Leung S. Y. Benzodiazepines, opioids and driving: an overview of the experimental research. Drug Alcohol Rev: 2011; 30 281 286
141. Berghaus G., Friedel B. Methadone and driver fitness. Euro-methwork Newsletter: 1998; 13 5 6
142. Schindler S. D., Ortner R., Peternell A. et al. Maintenance therapy with synthetic opioids and driving aptitude. Eur Addict Res: 2004; 10 80 87
143. Soyka M., Horak M., Dittert S. et al. Less driving impairment on buprenorphine than methadone in drug-dependent patients? J Neuropsychiatry Clin Neurosci: 2001; 13 527 528
144. Shmygalev S., Damm M., Weckbecker K. et al. The impact of long-term maintenance treatment with buprenorphine on complex psychomotor and cognitive function. Drug Alcohol Depend: 2011; 117 190 197
145. Sabatowski R. Driving ability under opioids: current assessment of published studies. Dtsch Med Wochenschr: 2008; 133 (Suppl 2) S25 S28
146. Dagtekin O., Gerbershagen H. J., Wagner W. et al. Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients. Anesth Analg: 2007; 105 1442 1448